Controlled delivery of peptides and proteins.

Abstract:

:The final aim/target of Pharmaceutical Sciences is to design successful dosage forms for effective therapy, considering individual patient needs and compliance. Development of new drug entities, particularly using peptides and proteins, is growing in importance and attracting increased interest, as they are specifically effective at a comparably low dose. These very potent and specific peptides and proteins can now be produced in large quantities due to increased knowledge and advancements in biotechnological and pharmaceutical applications. A number of peptide and protein products are now available on the market, and numerous studies investigating them have been published in the literature. Although many peptide/protein like products are generally designed for parenteral administration, some other noninvasive routes have also been used. For example, desmopressin is delivered nasally and deoxyribonuclease by inhalation. Although peptides and proteins are generally orally inactive, cyclosporine is an exception. In order to design and develop long-acting, more effective peptide/protein drugs, the controlled release mechanisms and effective parameters need to be understood and clarified. Therefore, we review herein various peptide/protein delivery systems, including biodegradable and nondegradable microspheres, microcapsules, nanocapsules, injectable implants, diffusion-controlled hydrogels and other hydrophilic systems, microemulsions and multiple emulsions, and the use of iontophoresis or electroporation, and discuss the results of recent researches.

journal_name

Curr Pharm Des

authors

Degim IT,Celebi N

doi

10.2174/138161207779313795

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

99-117

issue

1

eissn

1381-6128

issn

1873-4286

journal_volume

13

pub_type

杂志文章,评审
  • Adenosine and ischemic preconditioning.

    abstract::Adenosine is released in large amounts during myocardial ischemia and is capable of exerting potent cardioprotective effects in the heart. Although these observations on adenosine have been known for a long time, how adenosine acts to achieve its anti-ischemic effect remains incompletely understood. However, recent ad...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Liang BT,Jacobson KA

    更新日期:1999-12-01 00:00:00

  • TREX1 As a Potential Therapeutic Target for Autoimmune and Inflammatory Diseases.

    abstract:BACKGROUND AND OBJECTIVES:The 3' repair exonuclease 1 (TREX1) gene is the major DNA-specific 3'-5 'exonuclease of mammalian cells which reduces single- and double-stranded DNA (ssDNA and dsDNA) to prevent undue immune activation mediated by the nucleic acid. TREX1 is also a crucial suppressor of selfrecognition that pr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190902113218

    authors: Tao SS,Wu GC,Zhang Q,Zhang TP,Leng RX,Pan HF,Ye DQ

    更新日期:2019-01-01 00:00:00

  • Neurobiology of depression and novel antidepressant drug targets.

    abstract::Depression is one of the most common psychiatric conditions affecting numerous individuals in the world. However, the currently available antidepressant medication shows low response and remission rates. Thus, new antidepressants need to be discovered or developed. Aiming to describe the current neurobiological hypoth...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212803523581

    authors: Kern N,Sheldrick AJ,Schmidt FM,Minkwitz J

    更新日期:2012-01-01 00:00:00

  • Replication and transcription of the rotavirus genome.

    abstract::Rotaviruses are an important cause of human morbidity and mortality, representing the primary pathogens responsible for acute dehydrating diarrhea in children under the age of 3. The infectious rotavirus particle is made up of three concentric layers of protein, and contains a genome consisting of eleven segments of d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043382620

    authors: Patton JT,Vasquez-Del Carpio R,Spencer E

    更新日期:2004-01-01 00:00:00

  • Treatment Options in Alzheimer´s Disease: The GABA Story.

    abstract::Alzheimer's disease (AD) is the most common form of dementia in the elderly. Research focused on identifying compounds that restore cognition and memory in AD patients is a very active investigational pursuit, but unfortunately, it has been only successful in terms of developing symptomatic treatments. Aβ deposition a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150914121149

    authors: Solas M,Puerta E,Ramirez MJ

    更新日期:2015-01-01 00:00:00

  • Role of DAP12 in innate and adaptive immune responses.

    abstract::DAP12 is a novel immunoreceptor tyrosine-based activation motifs (ITAM)-bearing transmembrane adapter molecule. This molecule, together with its partner receptor complex molecules including the killer cell activating receptors (KARs), myeloid DAP12 associating lectin-1 (MDL-1), triggering receptor expressed on myeloid...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033392503

    authors: Aoki N,Kimura S,Xing Z

    更新日期:2003-01-01 00:00:00

  • Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.

    abstract::The rapid advancement of computer architectures and development of mathematical algorithms offer a unique opportunity to leverage the simulation of macromolecular systems at physiologically relevant timescales. Herein, we discuss the impact of diverse structure-based and ligand-based molecular modeling techniques in d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190304123545

    authors: Samanta PN,Kar S,Leszczynski J

    更新日期:2019-01-01 00:00:00

  • Therapy against reperfusion-induced microvascular injury.

    abstract::No-reflow, i.e., the lack of distal myocardial perfusion to fully recover following recanalization of an acutely occluded coronary artery, is not only a mere consequence of ischemic injury, as substantial microvascular alterations may also develop subsequently, after initial restoration of perfusion. Since part of per...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990357

    authors: Tritto I,Zuchi C,Vitale S,Ambrosio G

    更新日期:2013-01-01 00:00:00

  • Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD).

    abstract::Inhaled glucocorticoids, also know as corticosteroids (ICS), revolutionized the treatment of asthma by suppressing airways inflammation and ICS therapy now forms the basis of treatment of asthma of all severities. More recently and usually in combination with a long-acting β-agonist (LABA), ICS use has been establishe...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161210793797889

    authors: Adcock IM,Marwick J,Casolari P,Contoli M,Chung KF,Kirkham P,Papi A,Caramori G

    更新日期:2010-01-01 00:00:00

  • Fibrate-associated adverse effects beyond muscle and liver toxicity.

    abstract::Fibrate derivatives have a 40-year history in the management of dyslipidemia. Although this class of drugs is generally well tolerated, several safety issues have arisen from their use. In the present article we review the literature describing side effects associated with the use of fibrates except for those that are...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783885362

    authors: Florentin M,Liberopoulos EN,Mikhailidis DP,Elisaf MS

    更新日期:2008-01-01 00:00:00

  • Smoking and cardiovascular system: cellular features of the damage.

    abstract::Two morphological features may be seen as a main result of the cardiovascular cell damage caused by cigarette smoking: myocardial cell necrosis and smoke cardiomyopathy that, however, can lead to cell necrosis in case of chronic prolonged exposure to tobacco smoke. Both these pathological patterns recognise hypoxia as...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784746699

    authors: Leone A,Landini L Jr,Biadi O,Balbarini A

    更新日期:2008-01-01 00:00:00

  • Developing antiangiogenic peptide drugs for angiogenesis-related diseases.

    abstract::Angiogenesis is regulated by stimulators and inhibitors and involve multiple biological processes including endothelial cell proliferation, migration, cell-cell and cell-matrix adhesion, assembly into tube structures as well as apoptosis. Designing and developing peptides for therapeutic application to inhibit angioge...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161207781039715

    authors: Sulochana KN,Ge R

    更新日期:2007-01-01 00:00:00

  • Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases.

    abstract::Cardiovascular diseases (CVD) are considered a major health problem worldwide, being the main cause of mortality in developing and developed countries. Endothelial dysfunction, characterized by a decline in nitric oxide production and/or bioavailability, increased oxidative stress, decreased prostacyclin levels, and a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200403172736

    authors: Blanco-Rivero J,Xavier FE

    更新日期:2020-01-01 00:00:00

  • Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease.

    abstract:BACKGROUND:A substantial part of literature has been centered on sex differences in the clinical aspects of ischemic heart disease (IHD). Many reports have documented differences in the presentation and risk profile between women and men. Such differences drive sex-related inequalities in the referral and treatment of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160311115344

    authors: Cenko E,Bugiardini R

    更新日期:2016-01-01 00:00:00

  • Pharmacological management of acutely agitated schizophrenic patients.

    abstract::Agitation is commonly seen in acute schizophrenic patients and core symptoms include a wide range of symptom. It requires rapid and effective treatment approaches in order to protect patient and caregiver from potential injury. Clinician's decision of pharmacological treatment should be individualized to the needs and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612054367472

    authors: San L,Arranz B,Escobar R

    更新日期:2005-01-01 00:00:00

  • The effect of Endovascular Aneurysm Repair on Renal Function in Patients Treated for Abdominal Aortic Aneurysm.

    abstract:AIM:The effect of endovascular aneurysm repair in patients treated for abdominal aortic aneurysm has not been clearly defined. The objective of the present article was to provide a contemporary literature review and perform an analysis to determine the effect of EVAR on renal function in the early post-operative period...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612825666191129094923

    authors: Nana P,Kouvelos G,Brotis A,Spanos K,Giannoukas A,Matsagkas M

    更新日期:2019-01-01 00:00:00

  • Sleep loss and hypertension: a systematic review.

    abstract::Hypertension and insomnia are very common and often coexist. There is evidence to suggest that the increasing prevalence of arterial hypertension in the past decade might be related both to an increased prevalence of insomnia and to the decline of sleep duration due to modern lifestyle. The aim of this paper is to rec...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319130009

    authors: Palagini L,Bruno RM,Gemignani A,Baglioni C,Ghiadoni L,Riemann D

    更新日期:2013-01-01 00:00:00

  • A leap into the chemical space of protein-protein interaction inhibitors.

    abstract::Protein-protein interactions (PPI) are involved in vital cellular processes and are therefore associated to a growing number of diseases. But working with them as therapeutic targets comes with some major hurdles that require substantial mutations from our way to design drugs on historical targets such as enzymes and ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212802651571

    authors: Villoutreix BO,Labbé CM,Lagorce D,Laconde G,Sperandio O

    更新日期:2012-01-01 00:00:00

  • Dietary free amino acids and the gastric phase of digestion.

    abstract::In the stomach, pre-absorptive perception of food constituents is of particular importance in maintaining secretion and motility that matches the quantity and quality of nutrients. Products of food protein hydrolysis, free amino acids and short peptides, are the most potent chemical stimulants of the gastric phase of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990581

    authors: Zolotarev VA

    更新日期:2014-01-01 00:00:00

  • Topical delivery of drugs for the effective treatment of fungal infections of skin.

    abstract::The prevalence of fungal infections of skin has increased rapidly, affecting approximately 40 million people across the globe. A wide variety of antifungal drugs has been utilized in the effective management of numerous dermatological infections. Topical treatment of fungal infections has proved to be quite advantageo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150428150456

    authors: Akhtar N,Verma A,Pathak K

    更新日期:2015-01-01 00:00:00

  • Correlation of Salusin Beta with hs-CRP and ADMA in Hypertensive Children and Adolescents.

    abstract:PURPOSE:The emerging evidence has recently shown an evident dependence between recently identified salusin peptides and atherosclerosis, and their important roles as endogenous modulators of atherogenesis. It was reported that the development of atherosclerosis could also be affected by endogenous salusin- β overproduc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612824666180607124531

    authors: Kołakowska U,Kuroczycka-Saniutycz E,Olański W,Wasilewska A

    更新日期:2018-01-01 00:00:00

  • Circular micro-proteins and mechanisms of cyclization.

    abstract::Transpeptidation reactions result in the formation of new peptide bonds and this can occur between two separate peptides or within the one peptide. These reactions are catalyzed by enzymes and when the N- and C-terminus of the one peptide are joined it results in the formation of cyclic proteins. Cyclization via head-...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211798999410

    authors: Conlan BF,Anderson MA

    更新日期:2011-12-01 00:00:00

  • Anticancer agents: tumor cell growth inhibitory activity and binary QSAR analysis.

    abstract::The tumor cell growth inhibitory activities (log 1/GI(50)) of 166 anticancer agents studied at the National Cancer Institute (NCI) in vitro anticancer screening program have allowed us to analyze the relative importance of physicochemical parameters in influencing the inhibitory activities. Increased molecular weight,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612043384925

    authors: Ren SS,Lien EJ

    更新日期:2004-01-01 00:00:00

  • Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development.

    abstract::Nitric oxide is a ubiquitous molecule involved in a variety of biological processes. The specific action of NO depends on its enzymatic sources namely neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) and all three isoforms have been localized in the gastrointestinal tract. Constit...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013398491

    authors: Barrachina MD,Panés J,Esplugues JV

    更新日期:2001-01-01 00:00:00

  • Effects of Bioactive Peptide on Inflammatory Bowel Disease, Focus on Signal Transduction and Intestinal Microbiota.

    abstract::Inflammatory Bowel Diseases (IBD) are now widely receiving attention. There are many reasons why people get IBD; for example, environment, smoking, family heredity, intestinal microbiota and so on. Antibiotics have not been proven effective and those suffering from IBD have begun to look for other effective drugs to t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180829103945

    authors: Ma Y,Yan W,Ding S,Fei Y,Liu G,Fang J

    更新日期:2018-01-01 00:00:00

  • A role for the complement system in rheumatoid arthritis.

    abstract::The production of autoreactive antibodies from self-reactive B cells results in the formation of immune complexes that deposit in tissue and fix complement, contributing to the pathogenesis of rheumatoid arthritis (RA). Earlier mouse models emphasize the importance of autoreactive antibodies formed against "self" prot...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053381936

    authors: Low JM,Moore TL

    更新日期:2005-01-01 00:00:00

  • An Overview on Various Approaches and Recent Patents on Buccal Drug Delivery Systems.

    abstract:BACKGROUND:Buccal delivery is an alluring course of organization for fundamental medication conveyance and it leads direct access to the systemic flow through the interior jugular vein sidesteps drugs from the hepatic first-pass digestion gives high bioavailability. OBJECTIVE:This article aims at buccal medication con...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200614182013

    authors: Targhotra M,Chauhan MK

    更新日期:2020-01-01 00:00:00

  • Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic pain.

    abstract::Chronic pain is a widespread healthcare problem affecting not only the patient but in many ways all the society. Chronic pain is a disease itself that endures for a long period of time and it is resistant to the majority of medical treatments that provide modest improvements in pain and minimum improvements in physica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140314150634

    authors: Del Bufalo A,Cesario A,Salinaro G,Fini M,Russo P

    更新日期:2014-01-01 00:00:00

  • Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.

    abstract::DNA methyltransferase (DNMT) and histone deacetylase are key enzymes mediating the epigenetic regulation of gene expression. DNA hypermethylation and/or histone deacetylation in promoter regions is often associated with downregulation or silencing of transcription. Epigenetic silencing of tumor suppressor genes plays ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990527

    authors: Xu S,Ren J,Chen HB,Wang Y,Liu Q,Zhang R,Jiang SW,Li J

    更新日期:2014-01-01 00:00:00

  • Angiotensin II type 1 and type 2 receptor-induced cell signaling.

    abstract::The octapeptide angiotensin II (Ang II) plays a homeostatic role in the regulation of blood pressure and water and electrolyte balance, and also contributes to the progression of cardiovascular remodeling. Ang II activates Ang II type 1 (AT1) receptor and type 2 (AT2) receptor, both of which belong to the seven-transm...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319170003

    authors: Akazawa H,Yano M,Yabumoto C,Kudo-Sakamoto Y,Komuro I

    更新日期:2013-01-01 00:00:00